Back to Search
Dossier
靶向钙粘蛋白17的纳米抗体及其应用
InventionActive
10Claims · 6 independent
§ Ⅰ
Dossier Overview
Applicant
北京荣瑷医学生物科技有限责任公司
Inventor
张海燕; 杨丹辉; 张胜男; 吴维海; 牛璘灿
IPC Classification
C07K 16/28 (2006.01)C12N 15/62 (2006.01)C12N 5/10 (2006.01)C07K 19/00 (2006.01)C12N 15/867 (2006.01)G01N 33/68 (2006.01)G01N 33/575 (2026.01)G01N 33/5753 (2026.01)A61K 40/31 (2025.01)A61K 40/11 (2025.01)A61K 40/42 (2025.01)A61K 40/20 (2025.01)A61P 35/00 (2006.01)
本发明涉及靶向钙粘蛋白17的纳米抗体及其应用,涉及免疫学和分子生物学技术领域,所述靶向钙粘蛋白17的纳米抗体的互补决定区的氨基酸序列包括如SEQ ID NO:23所示的CDR1、如SEQ ID NO:36所示的CDR2、氨基酸序列如SEQ ID NO:49所示的CDR3。本发明通过构建羊驼免疫噬菌体展示库,从中筛选出系列靶向钙粘蛋白17(CDH17)的纳米抗体分子,并在CDH17抗原蛋白、CDH17靶细胞和CDH17CAR‑T细胞等多种水平上验证了所述纳米抗体的功能和应用。
Sign in to read the full text
Claim 1 is shown. Create a free account to read all 10 claims, the full description, all drawings, translations and legal status.
- All claims
- Technical field
- Background
- Summary
- Drawing descriptions
- Detailed description
External Resources